These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Losartan does not affect the pharmacokinetics and pharmacodynamics of warfarin. Kong AN, Tomasko L, Waldman SA, Osborne B, Deutsch PJ, Goldberg MR, Bjornsson TD. J Clin Pharmacol; 1995 Oct; 35(10):1008-15. PubMed ID: 8568008 [Abstract] [Full Text] [Related]
7. The clinical pharmacokinetics of levofloxacin. Fish DN, Chow AT. Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926 [Abstract] [Full Text] [Related]
8. Effect of tolterodine on the anticoagulant actions and pharmacokinetics of single-dose warfarin in healthy volunteers. Rahimy M, Hallén B, Narang P. Arzneimittelforschung; 2002 Feb; 52(12):890-5. PubMed ID: 12572529 [Abstract] [Full Text] [Related]
13. No effect of the novel antidiabetic agent nateglinide on the pharmacokinetics and anticoagulant properties of warfarin in healthy volunteers. Anderson DM, Shelley S, Crick N, Buraglio M. J Clin Pharmacol; 2002 Dec; 42(12):1358-65. PubMed ID: 12463731 [Abstract] [Full Text] [Related]